Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
KLOW is a research-context name for a four-peptide blend that combines GHK-Cu, KPV, BPC-157, and TB-500 in a single vial
In 2026 the FDA moved several of these peptides back to Category 1 status, so they can be prescribed through licensed compounding pharmacies, though the agency notes the clinical data is still limited
This relatively small size researchers note allows for efficient study of its cellular signaling behavior compared to larger peptide compounds
Not for injection
US$ 29.55
US$ 29.52
US$ 27.40
US$ 27.87
US$ 28.16
:max_bytes(150000):strip_icc()/the-benefits-of-n-acetylcysteine-89416-primary-recirc-5a4235d9adfe45d19d276d024c537108.jpg)
